Laman UtamaPRQR • NASDAQ
ProQR Therapeutics NV
$1.83
27 Sep, 8:30:00 PTG GMT-4 · USD · NASDAQ · Penafian
SahamSekuriti tersenarai AS
Tutup sebelumnya
$1.78
Julat hari
$1.78 - $1.90
Julat tahun
$1.11 - $3.29
Permodalan pasaran
149.47J USD
Bilangan Purata
124.51K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(EUR)Jun 2024Perubahan T/T
Hasil
6.46J419.79%
Perbelanjaan pengendalian
10.06J0.07%
Pendapatan bersih
-2.69J66.32%
Margin untung bersih
-41.6793.52%
Pendapatan bagi setiap syer
-0.0465.24%
EBITDA
-2.89J64.84%
Kadar cukai berkesan
6.92%—
Jumlah aset
Jumlah liabiliti
(EUR)Jun 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
96.15J-25.21%
Jumlah aset
118.05J-20.23%
Jumlah liabiliti
85.20J-11.70%
Jumlah ekuiti
32.85J—
Syer tertunggak
81.68J—
Harga kepada buku
4.45—
Pulangan pada aset
-7.44%—
Pulangan pada modal
-16.97%—
Perubahan bersih dalam tunai
(EUR)Jun 2024Perubahan T/T
Pendapatan bersih
-2.69J66.32%
Tunai daripada operasi
-6.26J39.54%
Tunai daripada pelaburan
-267.00K9.18%
Tunai daripada pembiayaan
-282.00K56.14%
Perubahan bersih dalam tunai
-6.74J35.31%
Aliran tunai bebas
252.00K-79.74%
Perihal
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
Diasaskan
2012
Tapak web
Pekerja
157
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama